KALV
Price
$26.95
Change
-$0.00 (-0.00%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.43B
64 days until earnings call
Intraday BUY SELL Signals
XOMAO
Price
$25.36
Change
-$0.01 (-0.04%)
Updated
Jun 3, 01:24 PM (EDT)
Capitalization
N/A
Intraday BUY SELL Signals
Interact to see
Advertisement

KALV vs XOMAO

Header iconKALV vs XOMAO Comparison
Open Charts KALV vs XOMAOBanner chart's image
KALV vs XOMAO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KALV vs. XOMAO commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KALV is a StrongBuy and XOMAO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (KALV: $26.94 vs. XOMAO: $25.37)
Brand notoriety: KALV and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KALV: 36% vs. XOMAO: 51%
Market capitalization -- KALV: $1.43B vs. XOMAO: $0
KALV [@Biotechnology] is valued at $1.43B. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KALV’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • KALV’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAO is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KALV’s TA Score shows that 3 TA indicator(s) are bullish while XOMAO’s TA Score has 3 bullish TA indicator(s).

  • KALV’s TA Score: 3 bullish, 5 bearish.
  • XOMAO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, XOMAO is a better buy in the short-term than KALV.

Price Growth

KALV (@Biotechnology) experienced а +0.48% price change this week, while XOMAO (@Biotechnology) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.03%. For the same industry, the average monthly price growth was -2.51%, and the average quarterly price growth was +2.77%.

Reported Earning Dates

KALV is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV YTD gains are higher at: 66.811 vs. XOMAO (3.582). XOMAO has higher annual earnings (EBITDA): 47.8M vs. KALV (-187.27M). KALV has more cash in the bank: 309M vs. XOMAO (93.3M). XOMAO has less debt than KALV: XOMAO (132M) vs KALV (150M). XOMAO has higher revenues than KALV: XOMAO (11.7M) vs KALV (1.43M).
KALVXOMAOKALV / XOMAO
Capitalization1.43BN/A-
EBITDA-187.27M47.8M-392%
Gain YTD66.8113.5821,865%
P/E RatioN/AN/A-
Revenue1.43M11.7M12%
Total Cash309M93.3M331%
Total Debt150M132M114%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
41
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KALVXOMAO
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
21%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
21%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
19%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
15%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 2 days ago
20%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 6 days ago
22%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KALV
Daily Signal:
Gain/Loss:
XOMAO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
CHFRUB102.2310.69
+11.68%
Switzerland Franc - Russia Ruble
GBPCNY9.210.11
+1.15%
United Kingdom Pound - China Yuan
FTXN36.430.40
+1.11%
First Trust Nasdaq Oil & Gas ETF
NZDCAD0.80-0.03
-3.11%
New Zealand Dollar - Canadian Dollar
AUDGBP0.51-0.02
-3.99%
Australian Dollar - United Kingdom Pound

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with REPL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
N/A
REPL - KALV
35%
Loosely correlated
-1.44%
AMLX - KALV
35%
Loosely correlated
-5.54%
SYRE - KALV
34%
Loosely correlated
-1.96%
CELC - KALV
33%
Loosely correlated
-25.66%
ABEO - KALV
33%
Loosely correlated
+1.15%
More

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
+0.08%
AMLX - XOMAO
68%
Closely correlated
-5.54%
NRSN - XOMAO
26%
Poorly correlated
-1.57%
ATAI - XOMAO
24%
Poorly correlated
-0.31%
LTRN - XOMAO
23%
Poorly correlated
N/A
KALV - XOMAO
23%
Poorly correlated
N/A
More